InspireMD (NSPR) EBITDA Margin Growth (5y) (2015 - 2025)
InspireMD (NSPR) EBITDA Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | InspireMD | 56.92 Mn | 2.71 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 196,942.00 |
| Sep 30, 2025 | -29,330.00 |
| Jun 30, 2025 | 4,924.00 |
| Mar 31, 2025 | -55,405.00 |
| Dec 31, 2024 | -23,322.00 |
| Sep 30, 2024 | -25,484.00 |
| Jun 30, 2024 | -31,376.00 |
| Mar 31, 2024 | 26,355.00 |
| Dec 31, 2023 | -6,144.00 |
| Sep 30, 2023 | -10,506.00 |
| Jun 30, 2023 | -17,546.00 |
| Mar 31, 2023 | -15,965.00 |
| Dec 31, 2022 | -30,735.00 |
| Sep 30, 2022 | -3,176.00 |
| Jun 30, 2022 | 5,269.00 |
| Mar 31, 2022 | 4,329.00 |
| Dec 31, 2021 | 36,546.00 |
| Sep 30, 2021 | -154.00 |
| Jun 30, 2021 | -437.00 |
| Mar 31, 2021 | 3,114.00 |